Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free catalyst technology enabling high-purity chiral secondary amines with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107602473A details a copper-catalyzed route for estrogen receptor ligands offering mild conditions and high yield for reliable pharmaceutical intermediate supply chains.
Advanced HCl-based recrystallization method ensures >99.5% purity and >90% yield, offering a reliable supply chain solution for oncology drug manufacturers.
Patent CN115197228A reveals efficient Rh-catalyzed synthesis of spiro compounds. Discover cost reduction in fine chemical manufacturing and high-purity intermediate supply solutions.
Patent CN101585758B introduces a novel trifluoromethanesulfonic acid mediated route for 5-hydroxy-1-indanone, offering superior scalability and cost efficiency for global supply chains.
Patent CN112441908B details a novel two-stage oxidation of 2,6-DIPN to produce 2,6-NDA with ultra-low aldehyde impurities, ensuring superior polyester quality.
Advanced synthesis of N-cyanomethylbis trifluoromethyl nicotinamide via patent CN107286086B. High-purity standard for flonicamid monitoring with optimized recycling.
Advanced synthetic route for Nifuratel Related Substance A Hydrochloride via epichlorohydrin. High purity, scalable process for pharmaceutical quality control and impurity profiling.
Novel preparation method for Nifuratel impurity C via epichlorohydrin cyclization. High yield, high purity process suitable for commercial scale-up and regulatory compliance.
Patent CN106892936B details a novel route for secondary trifluoromethyl propargyl alcohol, offering improved stability and supply chain reliability for pharmaceutical intermediates.
Novel synthesis route for Ondansetron intermediate offers high purity and yield, reducing costs and supply chain risks for pharmaceutical manufacturers globally.
Novel one-pot method reduces alcohol by-products. Enhances supply chain reliability for high-purity secondary diamine manufacturing with significant cost advantages.
Novel method for 2-nitro-4-thiophenyl aniline production. High yield, low waste. Cost-effective veterinary intermediate manufacturing solution.
Patent CN1077881C details a regiospecific route to cis-1-amino-2-indanol from diols or halohydrins, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for HIV protease inhibitors.
Discover a novel preparation method for 17 alpha-pregnenolone via selective acylation. Achieve >99.8% purity without chiral HPLC for reliable pharmaceutical intermediate supply.
Novel oxidation method for tofacitinib impurity ensures high purity and supply continuity. Cost-effective process avoids heavy metals for reliable pharmaceutical intermediates manufacturing.
Novel Lewis acid catalyzed route offers high purity 2-aminoindan with reduced cost and enhanced safety for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105063162A reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability in pharmaceutical manufacturing processes.
Patent CN114671922A details a mild, high-yield synthesis for Fulvestrant Related Substance IV. Discover cost-effective QC reference standards without column chromatography.
Patent CN114560761B enables green aqueous synthesis of indanone derivatives. Achieve high purity and cost reduction in API intermediate manufacturing with scalable rhodium catalysis.